Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001140361-16-054109
Filing Date
2016-02-19
Accepted
2016-02-19 12:43:59
Documents
1
Effectiveness Date
2016-02-19
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7610
  Complete submission text file 0001140361-16-054109.txt   8643
Mailing Address 676 CLIPPER STREET, #2 SAN FRANCISCO CA 94114
Business Address 676 CLIPPER STREET, #2 SAN FRANCISCO CA 94114 (415) 710-6702
Revitope Oncology, Inc. (Filer) CIK: 0001667518 (see all company filings)

EIN.: 811138303 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-257799 | Film No.: 161441097